Erythromycin
-
Post Date:
Oct 29,2013
-
Expiry Date:
Nov 12,2013
-
Detailed Description:
Cas No. :114-07-8
Name:
Erythromycin
Molecular Structure:
Formula:
C37H67NO13
Molecular Weight:
733.93
Deleted CAS:
374700-25-1
Synonyms:
Erythromycin A;Erymax;Pentadecanoic acid, 3-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]- 6,11,12,13-tetrahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4, 6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, .mu.-lactone, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-;Taimoxin-F;EM;Abomacetin;Abboticin;Erythro;Kesso-Mycin;Erythromid;Erycin;Propiocine;Ilotycin;Prestwick_205;6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione;Oxacyclotetradecane-2,10-dione, 4-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]- 14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4, 6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12S*,13S*)]-;
EINECS:
204-040-1
Density:
1.209 g/cm3
Melting Point:
138-140 °C
Boiling Point:
818.401 °C at 760 mmHg
Flash Point:
448.753 °C
Solubility:
soluble in ethanol, methanol and chloroform, insoluble in water
Appearance:
white to off white crystalline powder
Hazard Symbols:
Xn,Xi
Risk Codes:
42/43-36/37/38
Safety:
45-37-24-36-26
-
CAS Registry Number:
114-07-8
-
Synonyms:
;Abomacetin;Ak-Mycin;Aknin;Drmysin;E-Base;E.E.S;Emgel;EMU;E-mycin;Ergel;Eritocina;Eritrocina;Erthrogran;Eryacne;ERYC;Erycen;Erycette;Erycin;Erycinum;Ery Derm;Erymax;ERY-PED;ERY-TAB;Erythro;Erythroguent;Erythromast;Erythromast 36;Erythromid;Ilocap;Ilosone;Ilotycin;Inderm;L-alpha-Egg-phosphatidylcholine;P.C.E.;Pediamycin;Retcin;Robimycin;Statcin;Staticin;Stiemycin;Torlamicina;Torlamicna;T-Stat;Wintrocin;Wyamycin-s;6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name);(2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name);(3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);abboticin;
-
Molecular Formula:
C37H67NO13
-
Molecular Weight:
733.9268
-
Molecular Structure:
-
Hazard Symbols:
Xn:Harmful;
-
Risk Codes:
R42/43:;
-
Safety Description:
S24:;
S37:;
S45:;
-
Company:
WEIFANG VOT INTERNATIONAL BUSINESS CO.,LTD
[ China ]
-
Contact:
Miss.Wang
-
Tel:
0536-2456718
-
Fax:
0536-8231856
-
Email:
activesz@hotmail.com
Inquiry